Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment

American Journal on Addictions

Volumn 23, Issue 3, 2014, Pages 234-242

  Lee, Dayong ^a   Schroeder, Jennifer R ^a   Karschner, Erin L ^a   Goodwin, Robert S ^a   Hirvonen, Jussi ^b   Gorelick, David A ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CANNABINOID;

ADULT; AGED; ANXIETY; ARTICLE; CANNABIS ADDICTION; CANNABIS SMOKING; CHRONIC CANNABIS SMOKER; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DRUG BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; IRRITABILITY; LENGTH OF STAY; MALE; OUTCOME VARIABLE; PREVALENCE; RESIDENTIAL CARE; SLEEP DISORDER; SMOKING CESSATION; UNPLEASANT DREAM; WITHDRAWAL SYNDROME; APPETITE; BLOOD; COMPLICATION; INSOMNIA; METABOLISM; MIDDLE AGED; PSYCHOLOGY; SALIVA; SYMPTOM ASSESSMENT; YOUNG ADULT;

ADULT; ANXIETY; APPETITE; CANNABINOIDS; CRAVING; HUMANS; IRRITABLE MOOD; MALE; MARIJUANA ABUSE; MIDDLE AGED; SALIVA; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; SYMPTOM ASSESSMENT; YOUNG ADULT;

EID: 84898901159     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2014.12088.x     Document Type: Article

References (35)

1. Degenhardt L, Hall W., Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012; 379: 55-70.
2. SAMHSA. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings: Substance Abuse and Mental Health Services Administration; 2012.
3. Hasin DS, Keyes KM, Alderson D, et al. Cannabis withdrawal in the United States: Results from NESARC. J Clin Psychiatry. 2008; 69: 1354-1363.
4. Levin KH, Copersino ML, Heishman SJ, et al. Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend. 2010; 111: 120-127.
5. Budney AJ, Radonovich KJ, Higgins ST, et al. Adults seeking treatment for marijuana dependence: A comparison with cocaine-dependent treatment seekers. Exp Clin Psychopharmacol. 1998; 6: 419-426.
6. Allsop DJ, Copeland J, Norberg MM, et al. Quantifying the clinical significance of cannabis withdrawal. PLoS ONE. 2012; 7: e44864.
7. Budney AJ, Hughes JR, Moore BA, et al. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004; 161: 1967-1977.
8. Budney AJ, Hughes JR, Moore BA, et al. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry. 2001; 58: 917-924.
9. Georgotas A, Zeidenberg P., Observations on the effects of four weeks of heavy marihuana smoking on group interaction and individual behavior. Compr Psychiatry. 1979; 20: 427-432.
10. Nowlan R, Cohen S., Tolerance to marijuana: Heart rate and subjective "high." Clin Pharmacol Ther. 1977; 22: 550-556.
11. Haney M, Ward AS, Comer SD, et al. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl). 1999; 141: 395-404.
12. Preuss UW, Watzke AB, Zimmermann J, et al. Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. Drug Alcohol Depend. 2010; 106: 133-141.
13. Kouri EM, Pope HG., Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol. 2000; 8: 483-492.
14. Budney AJ, Moore BA, Vandrey RG, et al. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003; 112: 393-402.
15. Agnew HW, Webb WB, Williams RL., The first night effect: An EEG study of sleep. Psychophysiology. 1966; 2: 263-266.
16. Schwope DM, Karschner EL, Gorelick DA, et al. Identification of recent cannabis use: Whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem. 2011; 57: 1406-1414.
17. Lee D, Schwope DM, Milman G, et al. Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem. 2012; 58: 748-756.
18. Lee D, Milman G, Barnes AJ, et al. Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin Chem. 2011; 57: 1127-1136.
19. Hirvonen J, Goodwin RS, Li CT, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 2012; 17: 642-649.
20. Haney M, Ward AS, Comer SD, et al. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl). 1999; 141: 385-394.
21. Jones RT, Benowitz N, Bachman J., Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci. 1976; 282: 221-239.
22. Ellis BW, Johns MW, Lancaster R, et al. The St. Mary's Hospital sleep questionnaire: A study of reliability. Sleep. 1981; 4: 93-97.
23. Heishman SJ, Singleton EG, Liguori A., Marijuana Craving Questionnaire: Development and initial validation of a self-report instrument. Addiction. 2001; 96: 1023-1034.
24. Derogatis LR, Lipman RS, Covi L., SCL-90: An outpatient psychiatric rating scale-Preliminary report. Psychopharmacol Bull. 1973; 9: 13-28.
25. Lowe RH, Karschner EL, Schwilke EW, et al. Simultaneous quantification of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A. 2007; 1163: 318-327.
26. Milman G, Barnes AJ, Lowe RH, et al. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A. 2010; 1217: 1513-1521.
27. Gorelick DA, Levin KH, Copersino ML, et al. Diagnostic criteria for cannabis withdrawal syndrome. Drug Alcohol Depend. 2012; 123: 141-147.
28. Collins SL, Moore RA, McQuay HJ., The visual analogue pain intensity scale: What is moderate pain in millimetres ? Pain 1997; 72: 95-97.
29. 9- tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol. 2012; 36: 405-412.
30. Budney AJ, Novy PL, Hughes JR., Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999; 94: 1311-1322.
31. Gossop M, Johns A, Green L., Opiate withdrawal: Inpatient versus outpatient programmes and preferred versus random assignment to treatment. Br Med J (Clin Res Ed). 1986; 293: 103-104.
32. Hayashida M, Alterman AI, McLellan AT, et al. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med. 1989; 320: 358-365.
33. Mendelson JH, Mello NK, Lex BW, et al. Marijuana withdrawal syndrome in a woman. Am J Psychiatry. 1984; 141: 1289-1290.
34. Allsop DJ, Norberg MM, Copeland J, et al. The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011; 119: 123-129.
35. Vandrey R, Smith MT, McCann UD, et al. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug Alcohol Depend. 2011; 117: 38-44.